China Resources Double-Crane Pharmaceutical Co Ltd (600062) — Free Cash Flow Generation Index
China Resources Double-Crane Pharmaceutical Co Ltd (600062) has a Free Cash Flow Generation Index of 0.61x as of September 2025. Free cash flow of CN¥295.62 Million represents 1% of operating cash flow (CN¥487.90 Million). Explore China Resources Double-Crane Pharmaceuti (600062) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
China Resources Double-Crane Pharmaceutical Co Ltd Free Cash Flow Generation Index (1999–2024)
Historical FCF Generation Index trend for China Resources Double-Crane Pharmaceutical Co Ltd across 26 annual periods. For the full cash flow conversion analysis, see China Resources Double-Crane Pharmaceuti (600062) cash flow conversion.
Annual Free Cash Flow Generation for China Resources Double-Crane Pharmaceutical Co Ltd (1999–2024)
Year-by-year Free Cash Flow Generation Index for China Resources Double-Crane Pharmaceutical Co Ltd. Check China Resources Double-Crane Pharmaceuti total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.65x | CN¥1.19 Billion | CN¥1.83 Billion | CN¥637.50 Million | ▲ +4.7% |
| 2023 | 0.62x | CN¥1.03 Billion | CN¥1.65 Billion | CN¥614.31 Million | ▲ +2.2% |
| 2022 | 0.61x | CN¥816.14 Million | CN¥1.34 Billion | CN¥525.53 Million | ▼ -4.0% |
| 2021 | 0.63x | CN¥849.25 Million | CN¥1.34 Billion | CN¥491.67 Million | ▼ -14.9% |
| 2020 | 0.74x | CN¥1.01 Billion | CN¥1.36 Billion | CN¥348.09 Million | ▼ -10.6% |
| 2019 | 0.83x | CN¥1.20 Billion | CN¥1.44 Billion | CN¥241.65 Million | ▼ -1.4% |
| 2018 | 0.84x | CN¥1.24 Billion | CN¥1.47 Billion | CN¥228.69 Million | ▼ -2.9% |
| 2017 | 0.87x | CN¥1.03 Billion | CN¥1.19 Billion | CN¥154.82 Million | ▲ +1.4% |
| 2016 | 0.86x | CN¥661.20 Million | CN¥771.25 Million | CN¥110.04 Million | ▲ +12.8% |
| 2015 | 0.76x | CN¥532.86 Million | CN¥701.35 Million | CN¥168.49 Million | ▼ -5.2% |
| 2014 | 0.80x | CN¥576.00 Million | CN¥718.38 Million | CN¥142.38 Million | ▲ +33.3% |
| 2013 | 0.60x | CN¥328.56 Million | CN¥546.24 Million | CN¥217.68 Million | ▲ +36.8% |
| 2012 | 0.44x | CN¥174.16 Million | CN¥396.05 Million | CN¥221.89 Million | ▲ +30.2% |
| 2011 | 0.34x | CN¥172.74 Million | CN¥511.53 Million | CN¥338.78 Million | ▲ +23.4% |
| 2010 | 0.27x | CN¥139.50 Million | CN¥509.67 Million | CN¥370.18 Million | ▲ +64.6% |
| 2009 | 0.17x | CN¥56.85 Million | CN¥342.01 Million | CN¥285.16 Million | ▲ +145.0% |
| 2008 | 0.07x | CN¥22.51 Million | CN¥331.71 Million | CN¥309.20 Million | ▼ -83.9% |
| 2007 | 0.42x | CN¥99.29 Million | CN¥235.46 Million | CN¥136.17 Million | ▼ -3.0% |
| 2006 | 0.43x | CN¥132.05 Million | CN¥303.71 Million | CN¥171.66 Million | ▲ +380.8% |
| 2005 | 0.09x | CN¥12.64 Million | CN¥139.78 Million | CN¥127.13 Million | ▼ -84.0% |
| 2004 | 0.57x | CN¥256.88 Million | CN¥453.72 Million | CN¥196.84 Million | ▲ +137.1% |
| 2003 | -1.52x | CN¥-227.05 Million | CN¥148.94 Million | CN¥375.98 Million | ▼ -92.5% |
| 2002 | -0.79x | CN¥-111.35 Million | CN¥140.63 Million | CN¥251.99 Million | ▼ -222.9% |
| 2001 | -0.25x | CN¥-34.57 Million | CN¥141.01 Million | CN¥175.58 Million | ▼ -149.3% |
| 2000 | 0.50x | CN¥85.98 Million | CN¥172.81 Million | CN¥86.83 Million | ▲ +6.1% |
| 1999 | 0.47x | CN¥61.67 Million | CN¥131.54 Million | CN¥69.86 Million | — |